Posttraumatic stress disorder (PTSD) affects approximately 8% of the general population, with higher rates in extreme stress groups, including combat veterans or victims of sexual assault. Despite extensive study of the neurobiological correlates of PTSD, little is known about its molecular substrates. Here differential gene expression and network analyses of 4 prefrontal cortex (PFC) postmortem subregions of male and female PTSD subjects demonstrates extensive remodeling of the transcriptomic landscape. The data revealed a highly connected down-regulated set of interneuron transcripts in the most significant gene network associated with PTSD and integration of this data with genotype data from the largest PTSD GWAS identified the interneuron synaptic gene ELFN1 as conferring significant genetic liability for PTSD. We also identified marked sexual dimorphism in the transcriptomic signatures that could contribute to the higher rates of PTSD in women. Comparison with a matched major depressive disorder (MDD) cohort revealed significant divergence between the molecular profiles of subjects with PTSD and depression despite their high comorbidity. Our analysis provides convergent systems-level evidence of genomic networks within the PFC that contribute to the pathophysiology of PTSD in humans.
INTRODUCTION
Posttraumatic stress disorder (PTSD) is a persistent, maladaptive response to extreme stress that is characterized by re-experiencing, avoidance, and hyperarousal symptoms that can endure for life 1, 2 . PTSD has a prevalence of approximately 8% in the general population, but rates increase to 25-35% within groups who have experienced severe psychological stress, such as combat veterans, refugees, and assault victims [3] [4] [5] . The risk factors for developing PTSD are multifactorial [6] [7] [8] [9] [10] [11] [12] , and include history of prior stress exposure, level of social support, and premorbid psychological traits. PTSD is 30-40% heritable [13] [14] [15] [16] [17] [18] and recent studies provide evidence of genome-wide significant risk loci associated with PTSD [18] [19] [20] .
Epidemiological studies report that women are twice as likely to develop PTSD, as well as other anxiety-related disorders compared to men 21, 22 . Women also experience more severe, debilitating, and persistent symptoms, suggesting the formation of sex-specific neural alterations [23] [24] [25] . Similarly, there are sex differences in fear learning and extinction in both humans and rodents 26, 27 , and activation of the brain circuitry underlying the fear response, including the prefrontal cortex (PFC), amygdala, and hippocampus is sexually dimorphic, potentially contributing to higher sensitivity in females [28] [29] [30] .
Studies of the molecular underpinnings of PTSD have been limited largely to white blood cells , identifying altered expression levels of pro-inflammatory cytokines and genes related to glucocorticoid activity [31] [32] [33] . Here we report the first transcriptomewide analysis of gene expression changes in postmortem brain of a large cohort of PTSD subjects. The results demonstrate extensive transcriptional changes in 4 discrete PFC subregions, with both combined sex as well as sex specific PTSD transcriptome profiles. Consistent with recent genetic studies of PTSD, the global transcriptomic signatures for PTSD more closely resemble schizophrenia, autism, and bipolar disorder, indicative of some degree of convergent molecular pathologies. Transcriptome-wide association studies using the Million Veteran PTSD GWAS dataset identified pathogenic genes that are associated with PTSD risk and illness state. The results also show that despite the high rates of comorbidity, the transcriptomic signatures of PTSD and MDD differ significantly. These findings provide the first complete genomic analysis of human PFC in PTSD, demonstrating that psychological trauma profoundly alters the molecular landscape of the brain.
RESULTS

Transcriptomic profiling of PFC in PTSD subjects
RNA sequencing (RNA-seq) was used to characterize the transcriptomes of four PFC subregions from postmortem tissue of subjects diagnosed with PTSD and matched healthy controls (Table S1) : dorsolateral PFC (dlPFC; BA9/46), medial orbitofrontal cortex (OFC; BA11), dorsal anterior cingulate (dACC; BA24), and subgenual prefrontal cortex (sgPFC; BA25). These regions were chosen based on functional evidence, including reports of decreased volume in PTSD subjects 34 and have been implicated in emotional dysregulation by functional neuroimaging studies 35 . In addition, dlPFC has been targeted using transcranial magnetic stimulation as a treatment in both disorders 36 . For each brain region we examined 52 PTSD subjects (26 males, 26 females), 45 MDD (18 females, 27 males), and 46 control (20 females, 26 males). Comparison of the combined male and female control and PTSD cohorts identified 393 differentially expressed genes (DEGs) in the dlPFC, 170 DEGs in the OFC, 74 DEGs in the dACC, and 1 in the sgPFC (FDR <0.05) (Fig. 1A) . Additionally, significant differential regulation in PTSD of individual exons was observed from a total of 1356 genes in the dlPFC, 6862 genes in the OFC, 72 genes in the dACC, and 37 genes in the sgPFC (FDR<0.05). There was also significant differential exon-exon junction usage from 12 genes in the dlPFC, 3336 genes in the OFC, 1 gene in the dACC, and 0 genes in the sgPFC (FDR<0.05) ( Fig. 1A) .
We observed a small degree of overlap in the DEGs of each region, with the highest level in the dlPFC and OFC (30 DEGs) ( Fig. 1B) , lower levels between any 2 other regions, and only two genes (ELK1 and ADAMTS2) that overlap across 3 regions (dlPFC, OFC, and dACC). No DEGs overlapped between all four regions. We observed significant overlap between gene features, especially between differentially expressed genes and exons and differentially expressed exons and junctions (Fig. 1C) .
Gene ontology (GO) analysis of all DEGs in the combined PFC using gProfiler (https://biit.cs.ut.ee/gprofiler/gost) revealed multiple GO terms, with the top terms plotted for all gene features (gene, exon, and junction) ( Fig. 1D; Table S2 ); the top upregulated gene ontologies included synapse, neuron, and axon terms, while the top down-regulated DEGs were associated with different aspects of glia formation, actin binding, and small GTPase signaling.
A recent large GWAS of PTSD subjects by the Psychiatric Genomics Consortium identified similarities in the genes with high polygenic risk scores (PRS) for PTSD with those with schizophrenia (SCZ) and bipolar disorder (BPD) 37 . This finding was also observed in the most recent PTSD GWAS published using the Million Veteran Program data set 18 . Here we compared the PTSD transcriptomic signatures to a recent transcriptomic meta-analysis of other major psychiatric disorders, focusing on dlPFC 38 .
Our analysis of regionally specific transcriptomic correlations revealed similarly higher significant correlations of PTSD dlPFC gene expression with SCZ and BPD, as well as autism spectrum disorder (ASD), with a lower, nonsignificant correlation with MDD ( Fig.   1E; Fig S1) .
PTSD transcriptomic organization differences revealed by network co-expression analysis
To characterize the transcriptomic changes in PTSD, we performed robust weighted gene co-expression network analysis (rWGCNA) 39 and identified 66 modules (arbitrary color designation) and plotted the modules with significant numbers of DEGs in Fig. 2A (see Table S3 for complete list and membership). We employed ARACNE (Algorithm for the Reconstruction of Accurate Cellular Networks) to resolve the twodimensional structure of the most significant individual modules and identify significant, highly interconnected key drivers that are differentially expressed and are predicted to drive observed transcriptional changes within modules 40 . The module with the highest significance for association with PTSD, as well as number of DEGs and key drivers (coral2) ( Fig. 2B) is composed of 36 genes, 7 of which are key drivers; coral2 is comprised primarily of downregulated DEGs in the dlPFC (FDR=5.9X10 -12 ) and OFC (FDR=0.022). Notably, coral2 contains a number of down-regulated GABA-related DEGs (noted by green connections) in dlPFC that are also key drivers, including GAD2 (glutamate decarboxylase 2), SST (somatostatin), PNOC (prepronociceptin), and SLC32A (solute carrier family 32, member 1). In addition, ELFN1 (extracellular leucine rich repeat and fibronectin type III domain containing 10) and LHX6 (LIM homeobox 6) are down-regulated key drivers that are linked with regulation of GABA synapse formation and GABA neuronal differentiation, respectively [41] [42] [43] . We explored the possibility of transcriptome-wide changes to GABA related transcripts in PTSD ( Fig. 2C) and observed significant decreases in transcripts encoding GABA transporters (SLC32A1) and GABA-related neuropeptides (SST, PVALB, VIP, PNOC) with concurrent increases in GABA receptors and anchoring proteins (GABRA1, GABRA2, GPHN) indicating a possible compensatory response to loss of GABA function ( Fig.   2C ). Network comparisons can provide identification of cell-type marker genes within modules and allow for identification of PTSD-associated networks within specific cell types. Coral2, as well as 5 other modules were significantly enriched for markers of neuronal cell type. Other top identified modules were significantly enriched for markers of endothelial cells (4 modules), oligodendrocytes (3), microglia (6) , and astrocytes (4) ( Fig. S2 ).
Transcriptome-wide association studies identify gene cis-regulated expression in PTSD
Transcriptome-wide association studies (TWAS) were conducted to identify genes with expression that is significantly associated with PTSD using UTMOST (Unified Test for MOlecular Signatures) 44 . TWAS has several advantages, including grouping of gene variants, reducing multiple comparisons, increasing power of association testing 45, 46 , and enabling identification of potential transcriptomic effects caused by disease associated genetic variation. Convergence of gene expression changes in a PTSD dysregulated brain region with both illness state and genetic risk for illness would yield the most significant pathogenic markers of PTSD. We used the GTEx database 47 (Table S4 ). Seven cortical TWAS hits were also DEGs in the current transcriptomic data set (ELFN1, GJC1, LRRC37A, MAPT, MST1R, RBM6, and ZHX3). We identified 46 unique genes across all three tissues by TWAS ( Fig. 3B) , with cortical tissue accounting for ~30% of the TWAS signal ( Fig. 3C) . Moreover, we identified 17 DEGs that overlapped with the list of 77 highconfidence PTSD risk genes in the MVP study. Notably, we identified the highly connected GABA-related gene ELFN1. Further, our CNS TWAS identified the key driver UBA7 (Ubiquitin like modifier activating enzyme 7) ( Fig. 3D) as meeting genomewide significance ( Table S4 ).
Sex-specific transcriptomic changes in PTSD
We observed significant principal component (PC) effects for primary diagnosis (Dx; PC 2, P=0.0003), sex (PC 1, P=2.2 x10 -29 ; PC 2, P= 2.3X10 -72 ), age (PC 1, P=0.02), PMI (PC 1, P=0.0007), RIN (PC 1, P=1.5x10 -8 ), and race (PC 1, P=0.01) on total variance across all brain regions ( Table S5 ) and all of these factors were included in our model as covariates. Notably, sex had the most robust effect on variance with PTSD and there was a significant interaction for sex in our statistical model, indicating that there are highly significant sex-specific differences in the PTSD transcriptome.
Significant transcriptomic differences between males and females were observed in all PFC subregions ( Fig. 4A,B ; Table S6 ). Women exhibited more genes that were differentially expressed between PTSD and healthy controls: 2045 DEGs in the OFC and 1283 in the sgPFC, 38 DEGs in the dlPFC, and 0 in the dACC ( Fig. 4A ; Table S6 ).
The relatively large number of DEGs in female sgPFC and OFC compared to the combined-sex data set ( Fig. 1A) or male alone analysis ( Fig. 4B ) suggests that these regions are of particular importance to the pathophysiology of PTSD in women. Men exhibited many fewer DEGs comparing PTSD and controls, with the majority occurring in the dlPFC (84) and fewer in the OFC (2), sgPFC (2), and the dACC (1) ( Fig. 4B ; Table S6 ). There were very few regional DEGs overlapping between males and females ( Fig. 4C) . Cross-regional comparisons revealed strong overlap between the female OFC and sgPFC (622 genes) ( Fig. 4D ), but little cross-regional overlap in males ( Fig. 4E ).
Further analysis indicated that the small overlap observed between DEGs in males and
females with PTSD is not due to baseline sex differences in gene expression (Table   S7 ). These findings indicate that males and females with PTSD have unique, regional transcriptomic profiles with very little correlation in degree of transcript change or total number of DEGs.
Sex-specific PTSD transcriptomic organization and key driver differences revealed by gene co-expression analysis
Male and female co-expression networks that combined all four PFC regions identified numerous transcript co-expression modules ( Fig. 4F and G) . In the female WGCNA, we identified 69 modules, 68 of which contained female-specific DEGs ( Fig.   5A and Table S3 ) and in the male there were 59 modules, 18 of which contained malespecific DEGs ( Fig. 5B and Table S3 ). We identified modules sharing high levels of homology at the gene membership level ( Fig. S3 ; P<0.05; fold enrichment >20), notably, 43 of 69 female PTSD modules were conserved in male PTSD.
Examination of cell-type marker genes within modules revealed several sex specific PTSD modules that were enriched for cell-type marker genes; there were 7 modules enriched for endothelial cell markers in the female comparisons and 6 neuronenriched modules in the male comparison, indicating a sex-specific divergence in celltype associated molecular changes within the PFC (Figure S2) . We validated the RNA-seq findings on a subset of genes identified as key drivers in our network co-expression analysis ( Table S3 ). We performed quantitative real-time PCR on 39 individual key drivers identified in the top modules in figures 2 and 3. In the female comparison 90% of the key drivers (28 of 31) were significantly replicated in the correct, up or down direction; in males 100% (12 of 12) and in the combined-sex comparison 90% (9 of 10) of key driver DEGS replicated in the correct direction PCR (Table S8) .
Divergent and convergent genomic mechanisms between PTSD and MDD
The MDD psychiatric control group was assembled to control for quality of the tissue, manner of death (number of suicide cases-a known confounder), antemortem treatment, and substance abuse/dependence, as well as the high rate of comorbidity with PTSD (approximately 50% of newly diagnosed PTSD patients) 48 . We performed RNA-seq and bioinformatics analyses on the MDD cohort in the same manner as the PTSD cohort (summarized in Figure S4 and Tables S9 and S10). 38 , which shows higher (r<0.15), but still nonsignificant correlations. These findings are consistent with the disease correlation analysis in Figure 1E , showing that the PTSD transcriptome significantly correlates with SCZ, BPD, and ASD, but not MDD*. Similar to previous reports 30, 49 , we also observed sexspecific transcriptomic signatures in MDD ( Fig. S4B & C, Table S10 ). Since GABA related deficits have been reported in MDD 50, 51 and to compare with the current findings of GABA alterations in PTSD (Fig. 2B, C) , we examined GABA signaling transcripts in our MDD data set. We found significant GABA-related DEGs in MDD, some of which overlapped with PTSD, particularly in the dlPFC (e.g., GAD2, SST, PNOC, VIP) ( Fig. 5C) ; there were also dlPFC differences, with PVALB levels decreased in MDD and a small non-significant increases in PTSD. There were also regional differences between the OFC and sgPFC where we observed decreases in ELFN1, PNOC, and SST in MDD but no effects in PTSD ( Fig. 5C) The disparity in molecular signatures between PTSD and MDD was also tested at the level of network analysis. We calculated the correlation between MDD and PTSD for each module and the quantile of the correlation among 2000 permutations. Of the 47 combined sex MDD modules, 16 were convergent and 12 were divergent compared to PTSD (there was no effect on the remaining 19 modules); of the 59 female modules 9 are convergent and 19 are divergent; and of the 43 male modules 15 are convergent and 5 are divergent ( Fig. S5) . These findings indicate that, even for modules conserved on the gene membership level, relatively small subsets (~10% for female modules, ~35% for combined sex and male modules) display significant convergence between MDD and PTSD; notably, there were similar levels of divergent modules (~12-25% for male and combined sex, 33% for female modules).
Due to the high comorbidity between PTSD and MDD and interest in identifying converging molecular pathways in neuropsychiatric disorders, we further explored the modules with high convergence between MDD and PTSD to identify co-expression gene sets common to both disorders across all PFC subregions. We calculated modulelevel differential expression across both disease states ( Fig. 5D ) and identified 19 modules with high correlation for PTSD and MDD in the combined-sex comparison, 18 in the female, and 6 in the male comparisons (Fig S6A) Of particular interest was the appearance of a stable gene set with high pair-wise connectivity present across all three comparisons, made up of 8 genes, including the DNA methyltransfease GADD45B
(growth arrest and DNA damage induced 45b; Fig. 5E ). We also observed cell-type specific marker enrichment in many of the PTSD-MDD converging modules, in astrocytes, microglia and oligodendrocytes ( Fig. S6B-D) .
DISCUSSION
Here we present the first complete transcriptomic evaluation of human PFC in PTSD, made possible by the establishment of the National PTSD Brain Bank by the U.S. Department of Veterans Affairs 52 . This is the largest transcriptomic study of PTSD brain tissue to date and concurrently examines the transcriptomic state for a psychiatric control, MDD, providing both a comparison and control for these comorbid illnesses. This is also one of the largest MDD transcriptomic data sets and includes regions (OFC) not typically examined 53 . Further, we take advantage of data from the largest PTSD GWAS from the Million Veteran Program 20 to link risk loci and transcriptomic changes in PTSD.
Integration of transcriptomic data with genetic variant information enabled us to identify genes associated with PTSD risk and illness state. TWAS-UTMOST of CNS and cortical tissue identified 45 genes achieving genome-wide significance using the MVP data, two of which, ELFN1 and UBA7, are also DEGs and key drivers with multiple network connections. ELFN1 is downregulated in the dlPFC and is a key driver in the most significant combined-sex network ( Fig. 2B & C) ; it is also decreased in female dlPFC and dACC and is a key driver in a female-specific network ( Table S3 ). ELFN1 encodes a synaptic adhesion protein that acts as an allosteric modulator of group III metabotropic glutamate receptors 41 ; it is also required for synapse formation on SST GABA interneurons by recruiting presynaptic mGluR7 (metabotropic glutamate receptor 7) and GluK2 (glutamate receptor kainate 2) 42 . Notably, there are multiple GABA related transcripts that are significantly down-regulated key-drivers in the same network as ELFN1, including SST, PNOC (Prepronociceptin, a GABA interneuron maker), GAD2
(glutamic acid decarboxylase-2, GABA synthetic enzyme), and SLC32A1 (solute carrier family 32A1, GABA/glycine vesicular transporter), indicating a decrease in GABA interneuron transmission in PTSD (Fig. 2C) . These effects were specific to the dlPFC where there was some overlap with MDD, as previously reported 50, 51 . However, there were also significant differences in dlPFC (i.e., PVALB), as well as in OFC and sgPFC, with decreased GABA-related transcripts in MDD, but small increases or no effects in PTSD. The region-specific overlap in GABA transcripts in the dlPFC could account in part for PTSD and MDD comorbidity, while the differences in dlPFC, OFC and sgPFC could represent illness specific changes.
SST and other GABA interneuron deficits, identified in postmortem studies of MDD 50,51 and SCZ 54 , interfere with PFC gamma oscillations and thereby alter top-down inhibition of projection target regions 55 . The GABA deficit overlap suggests that similar effects could occur in PTSD. This is supported by preclinical [56] [57] [58] [59] [60] and human brain imaging 61, 62 studies reporting that PTSD pathophysiology is also linked to PFC dysfunction, which could impair inhibitory control of the amygdala, as well as other target regions that regulate fear and extinction behaviors. Identification of significant links between ELFN1 risk loci and decreased ELFN1 expression, and its role as a key driver in the top PTSD network that includes GABA-related key drivers (SST, PNOC, GAD2) that are also decreased, provides strong support for a connection with PFC dysfunction in PTSD. However, differences between MDD and PTSD in PFC subregions demonstrate illness specific effects that could contribute to disruption of local PFC circuits as well as target regions. Based on these findings, future studies using high resolution brain imaging approaches could probe for these PTSD vs. MDD subregion specific effects.
UBA7 is a key driver in a combined sex network (brown) ( Table S3 ) and in the most significant female PTSD module (orange), which is also enriched for endothelial cell specific markers (Fig. 4H) . UBA7 is downregulated in the OFC in both comparisons and in female sgPFC. Transcriptomic studies of peripheral tissue implicate inflammatory and GC signaling in PTSD 31 and UBA7 is a ubiquitin-like activating enzyme that is part of an inflammatory gene expression cascade 63 . In addition, the glucocorticoid receptor chaperone FKBP5 was identified as an upregulated key driver in the dlPFC of females with PTSD. Regulation of FKBP5 has also been reported in small, preliminary postmortem PTSD studies in OFC 64 and the sgPFC 65 and FKBP5 variants have been extensively implicated in risk for developing PTSD 66, 67 . These results indicate that FKBP5 and UBA7 act as hub genes with functional importance in PTSD molecular pathology, consistent with previous work implicating dysregulation of inflammatory and GC signaling as hallmarks of PTSD pathophysiology. These targets regulate high confidence networks of genes, and in the case of UBA7 are related to both risk loci and illness state and offer potential for therapeutic interventions.
Our results also demonstrate sex specific transcriptomic signatures across the PFC subregions, with relatively large numbers of genes regulated in most PFC regions of females, and fewer DEGs in males, except in dlPFC. Sex-specific, co-expression modules with only modest homology between females and male were also identified. These sex differences extend into the cell-type specificity of significant modules with female modules associated primarily with endothelial cells and male modules associated more with neurons. While the overall transcriptomic signature of male PTSD is markedly different from MDD ( Fig. 5 B) , this finding suggests male PTSD molecular pathology is more similar to depression than its female counterpart.
Recent evidence points to converging molecular mechanisms across neuropsychiatric disorders 38, 68, 69 , and because of the high rates of PTSD and MDD comorbidity (> 50%) we reasoned that MDD was an optimal psychiatric control to disentangle the differences and similarities in the two disorders. Consistent with previous reports 30 , large numbers of DEGs were identified in all PFC subregions of both males and females with MDD, particularly sgPFC and OFC (Table S10) but there was little overlap with PTSD. We further tested the concordance of the complete PTSD and MDD transcriptomes identified in the current study, and with a previous MDD metaanalysis 38 but found no significant correlations (Fig. 5B) . At the network level there were low levels of convergence, but there was a set of related genes that were consistently regulated across the combined-sex, female, and male PTSD and MDD modules. The overlap in this set of genes, which included GADD45B, was observed in the dlPFC, but there were also significant effects in the other subregions in MDD, but not PTSD. GADD45B is a stress and activity regulated DNA methyltransfease that has been implicated in long-term synaptic plasticity and cellular stress responses, and is a key modulator of epigenetic switching in neurological and psychiatric disorders 70 .
GADD45B functions in part via regulation of the promoters of FGF1 (fibroblast growth factor 1) and BDNF (brain derived neurotrophic factor) 70 , and has been implicated in preclinical models of depression 71 . There are currently no studies examining the role of GADD45B in preclinical models of PTSD, but the results indicate that this gene and its network partners represent a potential molecular intersection between PTSD and MDD pathology.
In conclusion, we present the first well-powered transcriptomic study of human postmortem brain, focused on PFC in PTSD and define molecular signatures that are common to both female and male PTSD subjects, as well as sex-specific transcriptional changes, including differentially expressed key drivers that are linked to PTSD genetic risk. The results provide strong evidence for the role of these and other key drivers in PTSD that will guide future functional studies in preclinical models. In addition, this extensive dataset represents an important resource and significant step forward in understanding the genomic architecture of the PTSD, as well as MDD brain by identifying the molecular pathways which are significantly involved in mediating the effects of trauma. Future investigations should include integrating brain transcriptomic profiles with those of peripheral tissue datasets to identify biomarkers of PTSD 72 , and neuroimaging to characterize cortical differences between PTSD and MDD. The results of this study further elucidate the molecular mechanisms underlying PTSD and will lead to improved diagnostic criteria and therapeutic interventions.
MATERIALS AND METHODS
Data Reporting
No statistical methods were used to predetermine sample size.
Human Subjects
Human autopsy brain tissue samples were obtained from the University of Pittsburg Medical Center and the National Center for PTSD Brain Bank (with consent of next of kin). Subjects were a mix of European-, Asian-, and African-American descent.
Males and females were group-matched for age, pH, and postmortem interval (PMI). Table S11 and includes presence of comorbid disorders, tobacco use, cause and manner of death and presence of drug and/or alcohol abuse. Inclusion criteria for PTSD, MDD and control cases were as follows: PMI<30 hours, age range >18 to <70. One hundred and forty-three subjects Psychiatric history and demographic information were obtained by psychological autopsies performed postmortem. Trained clinicians with informants best acquainted with the subject generated the necessary information for diagnosis. To avoid systematic biases PTSD, MDD and CON cases were characterized by the same psychological methods. Psychiatric diagnosis was determined by consensus diagnosis between two clinicians using DSM-IV 73 criteria using SCID-1 interviews that are adapted for psychological autopsy 74 and review of medical records.
Sociodemographic and clinical details are listed in
RNA-sequencing and Bioinformatics
RNA (20mg) from each PFC region was extracted using RNeasy Mini Kit with gDNA elimination, as described by the manufacturer (Qiagen). RNA integrity number (RIN) and concentration were assessed using a Bioanalyzer (Agilent). Libraries were constructed using the SMARTer® Stranded RNA-seq Kit (Takara Bio) preceeded by rRNA depletion using 1ug of RNA. Samples were bar coded for multiplexing and sequenced at 75 bp paired-end on an Illumina HiSeq4000. Samples were pooled eight per lane and sequenced at a depth of 50 million reads.
Data preprocessing and quality control. Sequences in FASTQ files were mapped to the human genome (Hg19) using STAR (version 2.5.3a) with reference genome and annotation GTF file downloaded from ENSEMBL (release 79, GRCh38), and then counted by featureCounts (version 1.5.3). ENSEMBL IDs were mapped with gene annotation using the biomaRt package in R. Samples with overexpressed mitochondria genes that account for more than half of total counts were filtered out.
Differential gene expression (DGE). DGE was calculated using the DESeq2 package
in R for each sex and brain-region specific group 75 We employed an adapted protocol 76 on BAM files to extract transcript feature counts from each cortical subregion using regtools 77 and bed_to_junctions from TopHat2 78 .
Gene co-expression network analysis. Network analysis was performed with the
WGCNA package using signed networks, either in sex and brain-region specific groups or in sex and disease-specific groups 39, 79 . Data was quantile normalized for GC-content using R package cqn and corrected for batch effects using ComBat by package sva.
Outliers were defined as samples with standardized sample network connectivity Z scores < -2 and were removed. A soft-threshold power of 6 was used for all studies to achieve approximate scale-free topology (R 2 >0.8). Networks were constructed using the blockwiseModules function. The network dendrogram was created using average linkage hierarchical clustering of the topological overlap dissimilarity matrix (1-TOM).
Modules were defined as branches of the dendrogram using the hybrid dynamic treecutting method, with a minimum module size of 20, merge threshold of 0.1, and negative pamStage. Modules are labelled by a random color for illustration purposes.
Genes that did not fall within a specific module are assigned the color grey. Module (eigengene)-disease associations were evaluated using a linear mixed effect model. We also used linear regression to test for association between module eigengenes and several covariates or confounders (age, race, PMI etc). Significance values were FDRcorrected to account for multiple comparisons. Genes within each module were prioritized based on their module membership (k ME ), defined as correlation to the module eigengene.
Transcript Network Organization Analysis. After retrieving log2 fold changes of each transcript in different sexes by region combinations, we assigned a significance level to each gene in modules defined by WGCNA modular analysis pipeline. The WGCNA analysis generated 4 background networks with different total modules that included female control, female PTSD, male control and male PTSD. Each module was named with a color which would be used for visualization and identification. Background networks were created to integrate differentially expressed genes (DEGs) and modular changes from different regions. The number of identified DEGs was counted for each module and a Fisher's exact test was utilized to test if DEGs are enriched in a specific module. The network structures of significant modules were visualized using igraph in R. Key drivers which are defined by connectivity with DEGs were labeled in network graphs. These analyses were done for modules in each background network.
To further identify key regulator (driver) genes of the modules identified by WGCNA, we applied the key driver analysis to the module-based weighted coexpression networks derived from WGCNA. WGCNA was used first to identify significant interactions between genes in each module based on their mutual information and then remove indirect interactions through data processing. An undirected Key Driver Analysis was performed using the R package KDA. KDA calculates connectivity to a specified depth between each signature gene and a hub signature gene with connection to a significant number of other signature transcripts defined as a key driver.
Correlation/Concordance with other Psychiatric disorders.
Microarray and RNAseq data from 700 postmortem cortical brain samples across 14 studies of multiple neuropsychiatric disorders (including MDD) were meta-analyzed in a previous study 38 .
We used Spearman's r to compare those DEG meta-analysis log 2 FC signatures to the PTSD and MDD DEG log 2 FCs in our cohorts and compared for all disease pairs. 
UTMOST-TWAS. UTMOST (Unified Test for
Quantitative PCR Methods
qRT-PCR was performed using primers designed to detect the transcript of all 40 key drivers in the most significant co-expression modules for the combined sex, female, and male. mRNA was isolated from the using the RNEasy Plus Mini Kit (Qiagen, Venlo, Netherlands); 1 ug of mRNA was reverse-transcribed into cDNA using the iScript cDNA 
Code Availability.
All code used in this study is freely available online and can be found at https://github.com/mjgirgenti/PTSDCorticalTranscriptomics
Data Availability
RNA-seq summary statistics generated and/or analyzed during the current study will be made available on GEO. Additionally, the data that supports the findings of this study are available for from the corresponding authors upon reasonable request. regions. c, Regional overlap in the number of DEGs between females (black) and males (red). d, Regional overlap in number of DEGs compares combined sex (brown) and female only DEGs (orange). e, Compares combined sex (brown) and male only DEGs (blue). Lighter color indicates lower number of overlapping genes, with progressively darker red indicating increasing numbers of overlapping genes. Circos plots displaying the degree of enrichment for DEGs (P<0.05) in female (f) and male (g) modules for PTSD. Each slice of the chart represents a coexpression module assigned a random color name. The key for the concentric circles is shown in the middle. The outer most concentric circles represent total DEGs across cortical region. The inner circles indicate cell-type specific markers for each module. Colors represent corrected FET P-values and a key is provided. Key driver and node representation of the most significant sex-specific PTSD associated modules, orange in females (h), and green in males (I) enriched for DEGs for each comparison. There is enrichment of endothelial markers within orange, and endothelial and microglial markers within green. Key drivers are outlined in pink and nodes are outlined in black with inner colors representing regulation of gene expression (up regulation black, down regulation grey) across brain regions in PTSD. . e, A stable gene set that includes GADD45b is indicated on the module memberships in both disease conditions. This gene set is significantly stable (DEGs in both PTSD and MDD across all sex-specific comparisons) and indicates a likely point of molecular convergence between the two diseases, particularly in the dlPFC. Figure 1 . Transcriptomic concordance comparisons between PTSD and other neuropsychiatric disorders. a, PTSD transcriptomic profiles were compared with 5 other neuropsychiatric disorders. Individual cortical regions were compared to meta-analyzed transcriptomic signatures for autism spectrum disorder (ASD), schizophrenia (SCZ), bipolar disorder (BP), major depression disorder (MDD*), alcohol abuse disorder (AAD), and control disease irritable bowel syndrome (IBS). There was a significant correlation between PTSD and ASD, SCZ, and BP in the dlPFC and significant correlation between PTSD and AAD in the dACC. b, Comparison of psychiatric control cohort MDD transcriptomic signature to the 5 psychiatric disorders.
Supplementary
Supplementary Figure 3. Correspondence between female and male PTSD coeexpression modules.
Homology was measured between all male and female modules with significant association with PTSD. Significant homology was observed in 42 modules with greater than 20% enrichment in module gene membership between females and males.
Supplementary Figure 5. Module correlation between PTSD and MDD gene coexpression modules.
The quantile of correlation among 2000 permutations was calculated for each PTSD and MDD module. Blue line indicates modules above the 97.5% quantile that are significantly convergent and the red line indicates the bottom 2.5% quantile that are significantly divergent. In the combined sex comparison(a) there are 16 convergent modules and 12 divergent modules, in females there are 9 convergent and 19 divergent modules(b), and in males there are 15 convergent and 5 divergent modules(c).
